Why Some Cannabis Research Can't Be Trusted

When billions of dollars are on the line, research gets messy.

When cannabis shows comparable efficacy to opioids—without the addiction or overdose risk—you can bet Big Pharma won't cheer it on for now....

That's why we're suddenly seeing more and more "studies" painting cannabis as dangerous. Dig a little deeper, and you'll find they're often backed by groups with every incentive to protect their profits. Like any statistical study, the data can be twisted just enough to mislead. That's why it's critical to read closely—and always stay skeptical.

I'm bullish on the medicinal properties of cannabis. But I stay skeptical until people like Ryan Castle put the numbers on the table. His team's meta-analysis—10,000 papers, ranked in the top 5% of research globally—is the largest study on medical cannabis and cancer to date. That evidence can't be ignored.

When it comes to medicine, efficacy versus placebo is always an important line to walk. But let's be real: if you're in pain and cannabis helps you—does it matter if it's "efficacy" or "placebo"? The goal of medicine is to alleviate suffering, full stop.

The stigma in the medical world is still thick. I've asked my own doctor about NIH's recent findings (National Institutes of Health)—he admitted he hasn't read them. If doctors aren't up to date on the latest science, how can they give patients every tool possible? Skepticism is good—but so is being open to new facts.

And speaking of skepticism… extraction teams still running without tracking the right parameters? You've got no shot at Extraction 2.0. Guesswork isn't an option anymore. Drop the flashlight, guys. Sensor time is here.

This week's episode dives into Ryan Castle's groundbreaking meta-analysis, the largest medical cannabis study to date, and what it means for science, medicine, and the fight against outdated narratives.